Lanham O'Dell & Company’s Merck MRK Stock Holding History

Lanham O'Dell & Company’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$283K	Buy	2,691 +2	+0.1%	+$188	0.08%	26
2025 Q3	$226K	Buy	2,689 +12	+0.4%	+$988	0.07%	36
2025 Q2	$212K	Buy	2,677 +2	+0.1%	+$159	0.09%	35
2025 Q1	$240K	Buy	2,675 +127	+5%	+$11.9K	0.14%	25
2024 Q4	$253K	Buy	+2,548	New	+$263K	0.14%	23
2024 Q1	–	Sell	-2,246	Closed	-$245K	–	30
2023 Q4	$245K	Buy	+2,246	New	+$233K	0.17%	25
2023 Q1	–	Sell	-3,880	Closed	-$430K	–	20
2022 Q4	$430K	Buy	3,880 +485	+14%	+$49.6K	0.94%	10
2022 Q3	$292K	Buy	3,395 +1,002	+42%	+$89.4K	1.04%	22
2022 Q2	$218K	Buy	+2,393	New	+$212K	1.08%	14

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lanham O'Dell & Company's MRK Position: Q4 2025 in Review

Lanham O'Dell & Company increased its Merck (MRK) stake by 0.07% in Q4 2025, buying an estimated $188 and bringing the position to 2,691 shares worth $283K. The position accounts for 0.08% of the portfolio, ranked #26.

Lanham O'Dell & Company first reported a position in MRK in Q2 2022 and has held it in 9 quarters since. The position peaked at $430K in Q4 2022. 3,652 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

Lanham O'Dell & Company held 2,691 shares of Merck worth $283K as of Q4 2025.
Lanham O'Dell & Company bought 2 Merck shares in Q4 2025, an estimated $188.
Merck made up 0.08% of Lanham O'Dell & Company's portfolio in Q4 2025, its #26 holding.
Lanham O'Dell & Company first reported a position in Merck in Q2 2022 and has held it in 9 quarters since.
Lanham O'Dell & Company's Merck position peaked at $430K in Q4 2022.
3,652 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on Lanham O'Dell & Company's 13F filing for Q4 2025, filed 12 Jan 2026.